L-Factor

Details

Top
Internal ID 9da2fcc6-2217-41b1-aeff-c0d19e907ce9
Taxonomy Lipids and lipid-like molecules > Fatty Acyls > Fatty alcohols
IUPAC Name (5S)-5-[(1S)-1-hydroxyhexyl]oxolan-2-one
SMILES (Canonical) CCCCCC(C1CCC(=O)O1)O
SMILES (Isomeric) CCCCC[C@@H]([C@@H]1CCC(=O)O1)O
InChI InChI=1S/C10H18O3/c1-2-3-4-5-8(11)9-6-7-10(12)13-9/h8-9,11H,2-7H2,1H3/t8-,9-/m0/s1
InChI Key WPWMAIDTZPLUGB-IUCAKERBSA-N
Popularity 1 reference in papers

Physical and Chemical Properties

Top
Molecular Formula C10H18O3
Molecular Weight 186.25 g/mol
Exact Mass 186.125594432 g/mol
Topological Polar Surface Area (TPSA) 46.50 Ų
XlogP 2.00
Atomic LogP (AlogP) 1.63
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 5

Synonyms

Top
SCHEMBL18193440

2D Structure

Top
2D Structure of L-Factor

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9887 98.87%
Caco-2 + 0.6434 64.34%
Blood Brain Barrier - 0.5000 50.00%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Mitochondria 0.6912 69.12%
OATP2B1 inhibitior - 0.8479 84.79%
OATP1B1 inhibitior + 0.9290 92.90%
OATP1B3 inhibitior + 0.9055 90.55%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior - 0.8783 87.83%
P-glycoprotein inhibitior - 0.9610 96.10%
P-glycoprotein substrate - 0.8507 85.07%
CYP3A4 substrate - 0.5553 55.53%
CYP2C9 substrate - 0.7939 79.39%
CYP2D6 substrate - 0.8410 84.10%
CYP3A4 inhibition - 0.8858 88.58%
CYP2C9 inhibition - 0.8551 85.51%
CYP2C19 inhibition - 0.7020 70.20%
CYP2D6 inhibition - 0.9517 95.17%
CYP1A2 inhibition - 0.7422 74.22%
CYP2C8 inhibition - 0.9656 96.56%
CYP inhibitory promiscuity - 0.9447 94.47%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.9600 96.00%
Carcinogenicity (trinary) Non-required 0.6708 67.08%
Eye corrosion - 0.8787 87.87%
Eye irritation + 0.7442 74.42%
Skin irritation + 0.6917 69.17%
Skin corrosion - 0.6333 63.33%
Ames mutagenesis - 0.8237 82.37%
Human Ether-a-go-go-Related Gene inhibition - 0.7455 74.55%
Micronuclear - 0.9900 99.00%
Hepatotoxicity - 0.5699 56.99%
skin sensitisation - 0.7341 73.41%
Respiratory toxicity - 0.6111 61.11%
Reproductive toxicity - 0.6459 64.59%
Mitochondrial toxicity + 0.5500 55.00%
Nephrotoxicity + 0.4828 48.28%
Acute Oral Toxicity (c) III 0.5153 51.53%
Estrogen receptor binding - 0.8431 84.31%
Androgen receptor binding - 0.7772 77.72%
Thyroid receptor binding - 0.8327 83.27%
Glucocorticoid receptor binding - 0.6339 63.39%
Aromatase binding - 0.8862 88.62%
PPAR gamma - 0.6432 64.32%
Honey bee toxicity - 0.9838 98.38%
Biodegradation + 0.6750 67.50%
Crustacea aquatic toxicity + 0.5276 52.76%
Fish aquatic toxicity + 0.8104 81.04%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL253 P34972 Cannabinoid CB2 receptor 97.82% 97.25%
CHEMBL2581 P07339 Cathepsin D 96.76% 98.95%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 90.23% 96.09%
CHEMBL3060 Q9Y345 Glycine transporter 2 89.47% 99.17%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.80% 97.09%
CHEMBL2274 Q9H228 Sphingosine 1-phosphate receptor Edg-8 87.63% 100.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.37% 91.11%
CHEMBL3359 P21462 Formyl peptide receptor 1 85.53% 93.56%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.79% 95.56%
CHEMBL4588 P22894 Matrix metalloproteinase 8 82.32% 94.66%
CHEMBL5845 P23415 Glycine receptor subunit alpha-1 81.23% 90.71%
CHEMBL1907605 P24864 Cyclin-dependent kinase 2/cyclin E1 80.53% 92.88%

Cross-Links

Top
PubChem 10511762
NPASS NPC169499